Inovio Pharmaceuticals, Inc.
PD1 AND PDL1 ANTIBODIES AND VACCINE COMBINATIONS AND USE OF SAME FOR IMMUNOTHERAPY
Last updated:
Abstract:
Disclosed herein is a vaccine comprising an antigen and PD1 antibody and/or PDL1 antibody. Also disclosed herein is a method for enhancing an immune response in a subject. The method may comprise administering the vaccine to the subject in need thereof.
Status:
Application
Type:
Utility
Filling date:
6 Oct 2020
Issue date:
25 Mar 2021